Citations should be made in the following way: Authors. Title. Eur Respir J 2015; 46: Suppl. 59, abstract number.
Citations should be made in the following way: Authors. Title. Eur Respir J 2015; 46: Suppl. 59, abstract number.
Resistance to therapy in lung cancer
Symposium Chairs: Fernando Gamarra (Straubing, Germany), Nicolas Reynoird (La Tronche, France)
Aims: To describe the main mechanisms of resistance to the drugs that are currently being used to treat lung cancer, present the theoretical strategies to overcome resistance and new drug developments and discuss the clinical implications of drug resistance along with recommendations for planning therapy.
Target audience: Clinicians who are treating lung cancer patients or are interested in new developments in thoracic oncology, pathologists, and researchers in the field of lung cancer.